The DOI matches its Crossref record; 48 of the 51 references it cites were found in a registry or an index.
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists
Abstract
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of similar evidence based position papers published in 2005 and 2007. The document contains chapters on definitions and classification, we now also proposed definitions for difficult to treat rhinosinusitis, control of disease and better definitions for rhinosinusitis in children. More emphasis is placed on the diagnosis and treatment of acute rhinosinusitis. Throughout the document the terms chronic rhinosinusitis without nasal polyps (CRSsNP) and chronic rhinosinusitis with nasal polyps (CRSwNP) are used to further point out differences in pathophysiology and treatment of these two entities. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. Last but not least all available evidence for management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is analyzed and presented and management schemes based on the evidence are proposed. This executive summary for otorhinolaryngologists focuses on the most important changes and issues for otorhinolaryngologists. The full document can be downloaded for free on the…
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Approximately 2% of viral rhinitis episodes are secondarily infected by bacterial organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, with subsequent presentation of acute bacterial infection.138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The development of acute, moderate to severe symptoms, and nasal purulence may be consistent with ARS or RARS rather than AR.1,137,138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nasal discharge is often purulent and may be discolored, with a tendency to be unilateral although may be bilateral.1,138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some improvement in NO has been described in patients with NAR or rhinosinusitis, but the evidence is very weak”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intranasal corticosteroids (INCs) (beclomethasone, budesonide, ciclesonide, fluticasone propionate, fluticasone furoate, mometasone, triamcinolone) have a potent antiinflammatory effect and have proven to be effective in treating NO in both rhinitis and rhinosinusitis, as shown in several international consensus statements [127-131].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [130]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In CRS with NP , endoscopic surgical treatment has been shown to be beneficial in patients with severe symptoms who do not respond to appropriate medical treatment [20,127,128,212-218] and may be more cost-effective [219,220].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Symptomatically, these conditions are characterized by nasal obstruction, nasal congestion, facial pressure or pain, anterior or posterior nasal discharge, and anosmia/hyposmia for varying durations of time.1,138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
The cited source says what the claim attributes to it.
In the citing paper
“International consensus statements [127,130] recommend the use of INCs for both ARS and CRS with NP or CRS without NP.”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [130]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Conversely, AR is typically not associated with purulent or unilateral nasal discharge.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A longer duration of illness suggests bacterial ARS.137,138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) statement, fever and elevated serum markers of inflammation (C-reactive protein or erythrocyte sedimentation rate) are also included as diagnostic criteria.138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In general, viral ARS is present for less than 10 days.”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Progressive worsening over a short period of time (ie, 5 days) is also suggestive of bacterial ARS.137,138”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [138]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“nasal obstruction has a prevalence close to the 30% in Europe”
From Role of Nasal Surgery in Adult Obstructive Sleep Apnea: A Systematic Review (2024) · cites this paper as [28]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In some patients, there is increasing evidence of the involvement of a neurogenic signaling mechanism that causes the sensation of NO in the absence of real obstruction of the nasal passages [20].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [20]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Efficacy has not been demonstrated in patients with CRS and NP [130].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Nasal saline irrigations for the symptoms of chronic rhinosinusitis
Harvey, R. J., Hannan, S. A., Badia, L., & Scadding, G. K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006394 · Cited by 194
Self-citationRetractedEuropean Position Paper on Rhinosinusitis and Nasal Polyps 2020
Fokkens, W. J., Lund, V. J., Hopkins, C., Hellings, P. W., Kern, R., Reitsma, S., Toppila-Salmi, S., Bernal-Sprekelsen, M., Mullol, J., Alobid, I., et al. (2020) · Rhinology journal · doi:10.4193/rhin20.600 · Cited by 5,882
Self-citationAzithromycin for prevention of exacerbations of COPD
Albert, R. K., Connett, J., Bailey, W. C., Casaburi, R., Cooper, J. A. D., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. K., Lazarus, S. C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104623 · Cited by 1,226
Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
Hastan, D., Fokkens, W. J., Bachert, C., Newson, R. B., Bislimovska, J. K., Bockelbrink, A., Bousquet, P., Brożek, G. M., Bruno, A., Dahlen, S.-E. K., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02646.x · Cited by 1,114
Self-citationSaiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Rhinosinusitis: Establishing definitions for clinical research and patient care
Meltzer, E. O., Hamilos, D. L., Hadley, J. A., Lanza, D. C., Marple, B. F., Nicklas, R. A., Bachert, C., Baraniuk, J., Baroody, F. M., Benninger, M. S., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.029 · Cited by 854
Self-citationDifferent types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease
Zhang, N., Zele, T. V., Perez-Novo, C. A., Bruaene, N. V., Holtappels, G., Ruyck, N. D., Cauwenberge, P. V., & Bachert, C. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.07.008 · Cited by 621
Self-citationWolter, J. M. (2002) · Thorax · doi:10.1136/thorax.57.3.212 · Cited by 516
Asthma in adults and its association with chronic rhinosinusitis: The GA 2 LEN survey in Europe
Jarvis, D., Newson, R., Lotvall, J., Hastan, D., Tomassen, P., Keil, T., Gjomarkaj, M., Forsberg, B., Gunnbjornsdottir, M., Minov, J., et al. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02709.x · Cited by 485
Self-citationOral steroids and doxycycline: Two different approaches to treat nasal polyps
Van Zele, T., Gevaert, P., Holtappels, G., Beule, A., Wormald, P. J., Mayr, S., Hens, G., Hellings, P., Ebbens, F. A., Fokkens, W., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.02.020 · Cited by 402
Self-citation
Research works printed but not linked: 3
- [1]1. Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl. 2005(18):1-87.
- [11]11. Jarvis D, Newson R, Lotvall J, Hastan D, Tomassen P, Keil T, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012 Jan;67(1):91-8.
- [26]26. Kudoh S, Kimura H, Uetake T, et al. Clinical effect of low-dose, long-term macrolide antibiotic chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis. 1984;22:254-54.
Cited by
Sorted by citations
Items 1,001–1,005 of 1,005
Olfactory dysfunction in acute rhinosinusitis: intranasal sodium hyaluronate as adjuvant treatment
Ciofalo, A., VINCENTIIS, M. D., Zambetti, G., ALTISSIMI, G., Fusconi, M., Greco, A., Ottaviano, G., & Magliulo, G. (2016) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-016-4277-x · Cited by 18
Sharma, S., Wormald, J. C. R., Fishman, J. M., Andrews, P., & Kotecha, B. T. (2019) · The Journal of Laryngology & Otology · doi:10.1017/s0022215119000240 · Cited by 16
Edward, J. A., Sanyal, M., Le, W., Soudry, E., Ramakrishnan, V. R., Bravo, D. T., Nguyen, A. L., Zarabanda, D., Kingdom, T. T., Hwang, P. H., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.02.002 · Cited by 13
What is the Impact of Positive Airway Pressure in Nasal Polyposis? An Experimental Study
Balsalobre, L., Pezato, R., Mangussi-Gomes, J., Gregorio, L., Haddad, F. L. M., Gregorio, L. C., & Fujita, R. (2019) · International Archives of Otorhinolaryngology · doi:10.1055/s-0038-1676095 · Cited by 10
Churg-Strauss Syndrome or Eosinophilic Granulomatosis with Polyangiitis
Izquierdo-Domínguez, A., Cordero Castillo, A., Alobid, I., & Mullol, J. (2015) · Sinusitis · doi:10.3390/sinusitis1010024 · Cited by 8
Self-citation
Metadata
- Authors
- Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., Georgalas, C., Goossens, H., Harvey, R., Hellings, P., Hopkins, C., Jones, N., Joos, G., Kalogjera, L., Kern, B., Kowalski, M., Price, D., Riechelmann, H., Schlosser, R., Senior, B., Thomas, M., Toskala, E., Voegels, R., Wang, D. Y., & Wormald, P. J.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Royal National Throat Nose and Ear Hospital (GB)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Ghent University (BE)
- University of Chicago (US)
- University of Pennsylvania (US)
- Lund University (SE)
- Auckland City Hospital (NZ)
- University of Amsterdam (NL)
- University of Antwerp (BE)
- UNSW Sydney (AU)
- KU Leuven (BE)
- Guy's Hospital (GB)
- University of Nottingham (GB)
- University of Zagreb (HR)
- Northwestern University (US)
- Medical University of Lodz (PL)
- University of Aberdeen (GB)
- Innsbruck Medical University (AT)
- Medical University of South Carolina (US)
- University of Southampton (GB)
- Universidade de São Paulo (BR)
- National University of Singapore (SG)
- Flinders University (AU)
- ORCID
- Venue
- Rhinology journal
- Publisher
- Stichting Nase
- Published
- 2012-03-01
- Volume
- 50
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0300-0729 (ISSN-L)
- OpenAlex
- W1885435857
- Cited by
- 2,387
- References
- 51
- Citations by year
- 2026: 39 · 2025: 83 · 2024: 104 · 2023: 100 · 2022: 140 · 2021: 166 · 2020: 243 · 2019: 248 · 2018: 215 · 2017: 189 · 2016: 185 · 2015: 193 · 2014: 156 · 2013: 121 · 2012: 79
- FWCI
- 171.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Rhinology Journal (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Scientific Electronic Library Online (São Paulo Research Foundation, Latin American and Caribbean Center on Health Sciences Information, Conselho Nacional de Desenvolvimento Científico e Tecnológico) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Health Sciences › Medicine › Surgery › Nasal Surgery and Airway Studies
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Keywords
- sinusitis, nasal polyps, chronic rhinosinusitis without nasal polyps, chronic rhinosinusitis with nasal polyps, acute sinusitis, cystic fibrosis, aspirin-exacerbated respiratory disease, immunodeficiency, allergic fungal rhinosinusitis, inflammatory mechanisms, disease management
- MeSH terms
- Adult, Child, Chronic Disease, Humans, Nasal Polyps, Rhinitis, Sinusitis, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
